These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7011964)

  • 1. Oxprenolol vs propranolol: a randomized, double-blind, multiclinic trial in hypertensive patients taking hydrochlorothiazide. Veterans Administration Cooperative Study Group.
    Hypertension; 1981; 3(2):250-6. PubMed ID: 7011964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol in the treatment of essential hypertension.
    JAMA; 1977 May; 237(21):2303-10. PubMed ID: 323525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    JAMA; 1982 Oct; 248(16):2004-11. PubMed ID: 6750167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United States experience with oxprenolol in hypertension.
    Friedman B; Gray JM; Gross S; Levit SA
    Am J Cardiol; 1983 Nov; 52(9):43D-48D. PubMed ID: 6356865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of propranolol and hydrochlorothiazide for thr initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. Veterans Administration Cooperative Study Group on Antihypertensive agents.
    JAMA; 1982 Oct; 248(16):1996-2003. PubMed ID: 6750166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical responses to oxprenolol in the elderly.
    Ellis RA
    Am J Cardiol; 1983 Nov; 52(9):62D-65D. PubMed ID: 6356866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of oxprenolol and propranolol.
    Materson BJ; Michael UF; Oster JR; Perez-Stable EC
    Clin Pharmacol Ther; 1976 Aug; 20(2):142-51. PubMed ID: 780037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.
    Vandenburg MJ
    Br J Clin Pharmacol; 1982 Nov; 14(5):733-7. PubMed ID: 7138753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.
    Massie B; MacCarthy EP; Ramanathan KB; Weiss RJ; Anderson M; Eidelson BA; Labreche DG; Tubau JF; Ulep D; Bartels D
    Ann Intern Med; 1987 Aug; 107(2):150-7. PubMed ID: 3300457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical trial.
    Materson BJ; Friedman BA; Hla KM; Neidorf BS; Gray JM; Glazer N; Gross S
    Drug Intell Clin Pharm; 1983 Jan; 17(1):51-4. PubMed ID: 6337801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension.
    Sassano P; Chatellier G; Amiot AM; Alhenc-Gelas F; Corvol P; Ménard J
    J Hypertens Suppl; 1984 Dec; 2(2):S75-80. PubMed ID: 6100880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.